| ADTX 0.01 127.27% | GDC 0.0181 -15.02% | SOXS 3.59 -19.51% | GPUS 0.359 -9.78% | SRXH 0.1245 -37.59% | BITO 8.56 -1.95% | TZA 4.02 -5.85% | SPCX 185 -3.56% | MRVL 310.58 7.27% | CDT 1.02 47.19% | NVDA 210.69 2.95% | INTC 133.99 10.64% | WKSP 0.7379 23.33% | INLF 0.1566 -64.20% | NOK 13.49 -2.46% | AAL 15.99 3.70% | AZTR 0.1717 -15.42% | CAST 8.07 56.70% | CRVO 4.24 11.29% | NFLX 77.38 0.55% | AMC 2.83 6.39% | QS 8.04 16.52% | FLEX 147.61 3.13% | GRAB 3.57 3.48% | SOFI 17.91 2.81% | YYGH 0.0803 -37.70% | AAPL 298.01 0.70% | ATPC 3.88 42.12% | RKLB 107.24 -0.69% | BAC 56.2 -0.58% | LNKS 2.68 67.50% | SMCI 30.66 10.37% | PFE 25.22 -2.70% | SPY 746.74 0.78% | RIG 5.31 -4.84% | AMZN 244.39 2.90% | PLUG 2.85 7.55% | CRWV 117.95 2.38% | TSLL 13.16 1.86% | ONDS 9.27 1.64% | CMCSA 22.43 -1.15% | MU 1133.99 8.70% | TQQQ 82.87 6.87% | BFLY 8.9 55.87% | NVD 4.75 -5.57% | SQQQ 36.75 -7.01% | MSFT 379.4 0.13% | CTSH 43.7 -10.49% | WPRT 2.26 21.51% | T 22.01 -1.92%

CNO Financial Group, Inc. (NYSE:CNO) Insider Sale and Financial Overview

CNO Financial Group, Inc. (NYSE:CNO) is a prominent player in the insurance industry, providing health and life insurance products. The company operates through its subsidiaries, including Bankers Life and Casualty Company, Colonial Penn Life Insurance Company, and Washington National Insurance Company. CNO competes with other insurance giants like MetLife and Prudential Financial. On February 12, 2026, Matthew J. Zimpfer, CNO's General Counsel, sold 30,970 shares of the company's common stock at approximately $42.93 each. This transaction leaves Zimpfer with 307,937 shares.

Despite this sale, CNO continues to reward its shareholders with a quarterly cash dividend of $0.17 per share, payable on March 24, 2026, to those recorded by March 10, 2026. CNO's financial metrics provide insight into its market position. The company's price-to-earnings (P/E) ratio is around 32.45, indicating investor confidence in its earnings potential. The price-to-sales ratio of 0.92 suggests that the market values CNO's sales at less than one times its revenue, while the enterprise value to sales ratio of 1.60 reflects its total valuation compared to sales. The enterprise value to operating cash flow ratio stands at approximately 10.71, showing how CNO's valuation compares to its cash flow from operations. The earnings yield is about 3.08%, offering a glimpse into the return on investment for shareholders.

Additionally, the debt-to-equity ratio of 1.54 highlights CNO's reliance on debt financing relative to its equity. CNO's annual meeting of shareholders is scheduled for May 12, 2026, and will be held virtually. Shareholders recorded by March 16, 2026, can participate, vote, and submit questions. Notably, Nina Henderson, a long-serving Board member, will retire at the end of her term, concluding with the annual meeting. Henderson has been instrumental as Chair of the Human Resources and Compensation Committee.

Published on: February 13, 2026